81 results on '"Fabbri, Leonardo M."'
Search Results
2. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study
3. The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study
4. Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
5. Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases
6. Inhaled long-acting muscarinic antagonists in asthma – A narrative review
7. Prevalence and risk factors for pulmonary embolism in patients with suspected acute exacerbation of COPD: a multi-center study.
8. Prevention of Chronic Obstructive Pulmonary Disease
9. Chronic cough in adults
10. Electrocardiographic features of patients with COVID-19 pneumonia
11. Multimorbidity in COPD, does sleep matter?
12. Response
13. COPD: What’s in a Name?
14. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study
15. Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study
16. Blood eosinophils for the management of COPD patients?
17. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
18. Baseline Symptom Score Impact on Benefits of Glycopyrrolate/Formoterol Metered Dose Inhaler in COPD
19. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
20. Fe de errores de “Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD” [Arch Bronconeumol. 2017;53:128–49]
21. Triple therapy for symptomatic patients with COPD
22. Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD
23. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
24. Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD
25. Management of patients with early mild asthma and infrequent symptoms
26. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial
27. Insights, attitudes, and perceptions about asthma and its treatment: a multinational survey of patients from Europe and Canada
28. Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States
29. Breakthroughs in internal and respiratory medicine
30. Eosinophilia in asthma: the easy way is not always the best
31. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial
32. Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial
33. Benralizumab: for asthma, not yet for COPD
34. Inhaled steroids in COPD: when should they be used?
35. Asthma in the elderly: what we know and what we have yet to know
36. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial
37. Erratum: asthma in the elderly: what we know and what we have yet to know
38. Identifying and Treating COPD in Cardiac Patients
39. Bradykinin-induced asthmatic fibroblast/myofibroblast activities via bradykinin B2 receptor and different MAPK pathways
40. Seasonal Distribution of COPD Exacerbations in the Prevention of Exacerbations With Tiotropium in COPD Trial
41. Prognostic role of clusterin in resected adenocarcinomas of the lung
42. Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial
43. Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients
44. Spirometric inclusion criteria of COPD patients in randomized clinical trials
45. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma
46. Heart Failure and Chronic Obstructive Pulmonary Disease
47. FEV 1 /FVC Fixed Ratio Again!
48. CARDIOVASCULAR EVENTS IN PATIENTS RECEIVING ROFLUMILAST: FINDINGS FROM A POOLED ANALYSIS OF 14 RANDOMIZED CLINICAL TRIALS INVOLVING OVER 12,000 PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
49. Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma
50. Early Right Ventricular Dysfunction in Smokers With COPD and Reduced Diffusion Capacity for Carbon Monoxide (Dlco)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.